Menu

Pharma News

picture 116

Generics manufacturers increase investment in injectables

Home/Pharma News | Posted 30/08/2013

Generic drugmaker Zydus Cadila, the fifth largest pharmaceutical company in India, is set to invest about US$15.8 million in building an FDA-approved injectables-manufacturing plant. The news in August 2013 came just as Aurobindo Pharma announced plans to spin-off its injectables business to strengthen that side of its operations further.

picture 116

Fresenius Kabi sets up generics joint venture in Indonesia

Home/Pharma News | Posted 23/08/2013

Fresenius Kabi, the generics unit of healthcare giant Fresenius, announced on 19 August 2013 that it had set up a joint venture with Indonesia-based PT Soho Global Health, acquiring a 51% share in its subsidiary PT Ethica Industri Farmasi.

Globe AA008897 V13H02

Perrigo expands global ambitions with Elan buy

Home/Pharma News | Posted 16/08/2013

US-based generics maker Perrigo Company (Perrigo) announced on 29 July 2013 that it would acquire Irish biotechnology company Elan Corporation (Elan) for US$8.6 billion.

Globe AA008897 V13H02

Pfizer prepares to split off generics business

Home/Pharma News | Posted 09/08/2013

Pfizer, the world’s largest research-based pharmaceutical company, has announced plans to split off its generics drug business into a separate commercial operation. News of the plans came as the company reported its second quarter 2013 results at the end of July.

Generic V13C05

Aspen makes deals with Merck and GSK

Home/Pharma News | Posted 09/08/2013

Generics manufacturer Aspen Pharmacare Holdings (Aspen) is expanding its brand-name business, first signing a deal with Pharma giant Merck, and then offering to buy two brand-name heart medications from GlaxoSmithKline (GSK).

Globe AA008897 V13H02

CFR pharma expands global ambitions with Adcock bid

Home/Pharma News | Posted 02/08/2013

Chile-based CFR Pharmaceuticals (CFR) has plans to become a global drugmaker. In its latest efforts it has made a US$1.3 billion cash-and-share offer for South Africa’s second-largest generics drugmaker Adcock Ingram (Adcock).

Health on a Budget V13D12

UK plans to cut drug prices by up to 20%

Home/Pharma News | Posted 05/07/2013

The UK’s Department of Health (DoH) has launched a consultation to strengthen the statutory pharmaceutical pricing scheme, which covers the prices the National Health Service (NHS) pays for brand-name drugs not covered by the voluntary Pharmaceutical Price Regulation Scheme (PPRS). The consultation is seeking views on a price cut on drug prices of between 10% and 20% to ensure the NHS continues to get good value for money.

Viagra V13F28

Viagra generics hit the market in Europe

Home/Pharma News | Posted 28/06/2013

The patent on Pfizer’s blockbuster erectile dysfunction drug Viagra (sildenafil) expired on 21 June 2013 in the UK, along with several other European countries.

Real Fake V13F14

Nigeria needs to combat fake drugs and ageing facilities

Home/Pharma News | Posted 14/06/2013

Nigeria has ageing drug-manufacturing facilities and a problem with imports of fake drugs, according to Mr Olakunle Ekundayo, Group Managing Director, Drugfield Pharmaceuticals.

Pills V13D05

Sun Pharma looking to buy Sweden’s Meda

Home/Pharma News | Posted 07/06/2013

India-based Sun Pharmaceutical Industries (Sun Pharma) is reportedly in talks to acquire Swedish drugmaker Meda for US$5–6 billion.